PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K113. A total of 48 filers reported holding PHOENIX BIOTECH ACQUISITION in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,786 | +17.2% | 108,750 | 0.0% | 0.00% | – |
| Q2 2023 | $6,645 | +166025.0% | 108,750 | 0.0% | 0.00% | – |
| Q1 2023 | $4 | -20.0% | 108,750 | 0.0% | 0.00% | – |
| Q4 2022 | $5 | -99.9% | 108,750 | 0.0% | 0.00% | – |
| Q3 2022 | $9,000 | -18.2% | 108,750 | 0.0% | 0.00% | – |
| Q2 2022 | $11,000 | -54.2% | 108,750 | 0.0% | 0.00% | – |
| Q1 2022 | $24,000 | – | 108,750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 163,538 | $1,636,000 | 0.09% |
| Telemetry Investments, L.L.C. | 121,614 | $23,000 | 0.04% |
| Radcliffe Capital Management, L.P. | 150,000 | $1,501,000 | 0.03% |
| Q Global Advisors, LLC | 170,785 | $37,000 | 0.02% |
| CANTOR FITZGERALD, L. P. | 363,548 | $79,000 | 0.01% |
| Atalaya Capital Management LP | 225,000 | $50,000 | 0.01% |
| MMCAP International Inc. SPC | 375,000 | $82,000 | 0.01% |
| Bulldog Investors, LLP | 54,745 | $11,000 | 0.00% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 108,741 | $24,000 | 0.00% |
| Context Capital Management, LLC | 200,000 | $44,000 | 0.00% |